MARY COLE: Open Payments
NPI 1518377522 · DECATUR, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$728 in 22 payments from 9 companies in 2025. Trend: 2023 $288 · 2024 $843 · 2025 $728
Food & beverage: $728
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $279 |
| Axsome Therapeutics, Inc. | 5 | $169 |
| Lilly USA, LLC | 6 | $144 |
| Corcept Therapeutics | 2 | $35 |
| Astellas Pharma US Inc | 1 | $35 |
| Inspire Medical Systems, Inc. | 1 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $7 |
Products named: AIRSUPRA, Auvelity, BREZTRI, Korlym, Veozah, INSPIRE, MOUNJARO, Kerendia.
Industry payments across IN — which companies pay providers there.
